Definitive Contract 75F40124C00031
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a definitive, firm fixed-price contract to Infotrend Incorporated, an SBA certified 8(a) small business, to provide support for the CDER Electronic Submissions Program (ESP). The contract has a potential value of $2,197,459.87 and a completion date of March 21, 2021. As an 8(a) sole source award, this contract leverages a small business set-aside program to engage a minority-owned firm specializing in data...
- The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...
- This contract award is for the Electronic Submissions Gateway (ESG) Operations and Maintenance and ESG System Development Support. The contract was awarded by the Department of Health and Human Services Food and Drug Administration to the prime contractor, Information Innovators, LLC, a for-profit limited liability company. The contract has a potential value of $3,378,918.23 and is a delivery order under the Enterprise System Lifecycle Management Support (ELMS) master Indefinite...
- This federal contract award is for the CSFAN Regulatory Data Support & Modernization (RDSM) project, which was exercised as Option 2 under a larger contract. The prime contractor is Trigent Solutions Inc., a minority-owned, self-certified small disadvantaged business that is also certified as an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and Women-Owned Small Business (WOSB). The contract has a ceiling value of $9,995,337.03 and is a Delivery Order under the Chief...
- The Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has awarded a firm fixed price delivery order valued at $3.5M to Agisol LLC for regulatory review systems analysis and sunset support services. The contract, which commenced on July 16, 2025, and is scheduled for completion by January 20, 2027, will be performed in Silver Spring, Maryland. This delivery order is issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion...
- The Food and Drug Administration awarded a delivery order valued at $9.98 million to Systems Intelligence, LLC for an Electronic Records Retention Project task order. This firm fixed-price delivery order was issued on February 12, 2026, with an ultimate completion date of December 13, 2030, and will be performed in Rockville, Maryland. The contract carries no set-aside designation and represents work under Systems Intelligence's existing federal contracting vehicles with the FDA. Systems...
- The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
- The U.S. Food and Drug Administration (FDA) awarded a $122,611.14 task order to Brillient Corporation, a minority-owned digital transformation company, under a Professional and Technical Services Blanket Purchase Agreement. The award, made on July 12, 2023, is designated as a Competitive 8(a) set-aside and is scheduled for completion by May 25, 2026. Work will be performed in Reston, Virginia, with pricing structured on a time and materials basis. The task order supports the FDA's Center for...
- This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Infinisource Consulting Solutions, Inc., a minority-owned, woman-owned small business. The $3,996,829.92 firm-fixed-price contract is for shipping, receiving, and storeroom operations services at FDA's Center for Food Safety and Applied Nutrition (CFSAN) facilities in the Baltimore/Washington metropolitan area. The contract has a base year and four one-year option periods, with a completion...
- The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call to Spatial Front Inc., an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and SBA-certified 8(a) Program participant based in Bethesda, Maryland. This labor-hour contract, valued at $658,670.86, was awarded on August 9, 2022, and completed on August 31, 2023, to provide task management support to the Center for Drug Evaluation and Research (CDER) Office of the Center Director. The work was...
The Food and Drug Administration (FDA) awarded a definitive firm fixed-price contract to Infotrend Incorporated, an SBA-certified 8(a) small disadvantaged business based in College Park, Maryland, to provide support for the Center for Drug Evaluation and Research (CDER) Electronic Submissions Program (ESP). The contract was awarded on March 7, 2024, with a ceiling value of approximately $4.5 million and an ultimate completion date of May 21, 2027. This represents the exercise of option year 2 under the broader contract vehicle, and no set-aside designation was utilized for this award despite the contractor's small business status. Infotrend Incorporated specializes in comprehensive IT services to federal agencies, with demonstrated expertise in electronic submissions program support, data management, and technology modernization across civilian government entities. The contractor maintains multiple high-value indefinite delivery vehicles, including OASIS+ contracts and the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), positioning it as a versatile provider of professional services. Through this FDA engagement, Infotrend will continue to leverage its established experience supporting the agency's critical electronic submissions infrastructure, which facilitates the submission and management of regulatory documents for drug applications and other CDER functions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $1.5m | 3/9/26 | |
| P00001 | Exercise an Option | $1.4m | 3/16/25 | |
| Not listed | Not listed | $1.4m | 3/6/24 |